¼Ò¾Æ Àü½ÅÈ«¹Ý·çǪ½º ȯÀÚ¿¡¼ ¹ß»ýÇÑ ´ë½Ä¼¼Æ÷È°¼º ÁõÈıº
A Case of Macrophage Activation Syndrome Developed in Female Adolescent with Systemic Lupus Erythematosus
´ëÇÑ·ù¸¶Æ¼½ºÇÐȸÁö 2014³â 21±Ç 2È£ p.96 ~ p.100
±Ý½Â¿ì(Keum Seung-Woo) - °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
±è¹ÎÀç(Kim Min-Jae) - °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
¹èÀÌ¿µ(Bae E-Young) - °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
Çѽ¹ü(Han Seung-Beom) - °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
Á¤³«±Õ(Chung Nack-Gyun) - °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
Á¤Ã¢¸ð(Jeong Chang-Mo) - °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
°ÁøÇÑ(Kang Jin-Han) - °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
Abstract
Macrophage activation syndrome (MAS) is a severe com-plication in patients with autoimmune disease. We should consider MAS in patients with autoimmune disease, who present with newly developed fever, and MAS needs prop-er management due to grave outcome. We report a case of MAS in a 15-year-old adolescent girl, who was newly diagnosed with systemic lupus erythematosus 1 month be-fore the diagnosis of MAS. Her MAS was improved by in-tensive treatment, including etoposide.
Å°¿öµå
Macrophage activation syndrome, Systemic lu-pus erythematosus, Adolescent
KMID :
0388220140210020096
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)